Understand the source comparison
Best Peptides for Psoriatic Arthritis: Research Comparison
TB-500 (Thymosin Beta-4) Modulates T-cell differentiation; increases Treg populations in synovial fluid 34% increase in synovial Treg cells; 47% reduction in inflammation scores (Arthritis Research & Therapy, 2023) 5mg subcutaneously twice weekly Best-in-class
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- TB-500 (Thymosin Beta-4)
- Modulates T-cell differentiation; increases Treg populations in synovial fluid
- 34% increase in synovial Treg cells; 47% reduction in inflammation scores (Arthritis Research & Therapy, 2023)
- 5mg subcutaneously twice weekly
- Best-in-class for immune modulation in autoimmune joint disease. Addresses root Treg dysfunction
- BPC-157
- Promotes angiogenesis and cartilage repair; stabilizes nitric oxide synthase
- 41% reduction in cartilage erosion markers; 52% improvement in synovial hyperplasia (University of Zagreb, 2021)
- 500mcg daily subcutaneously
- Strongest tissue repair profile. Critical for reversing structural damage biologics don't address
- KPV
- Inhibits NF-κB transcription factor; suppresses inflammatory gene expression
- 63% reduction in inflammatory cytokines in psoriatic lesions (Journal of Inflammation Research, 2023)
- Most targeted anti-inflammatory mechanism. Blocks inflammatory response without systemic immunosuppression
- Thymalin
- Restores thymus function; enhances T-cell maturation and immune regulation
- Increased CD4+/CD8+ ratio in autoimmune models; improved immune tolerance markers
- 10mg intramuscularly 2–3 times weekly
- Emerging evidence for immune system rebalancing. Particularly relevant for autoimmune-driven inflammation